Hodgkin’s and non-Hodgkin’s lymphomas (NHL)

The enhancing oncology model and other value-based propositions

Addressing cancer disparities in Hispanic populations in the US and in low and middle income countries

Addressing cancer disparities in Hispanic populations in the US and in LMICs

Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma

The role of the workforce in implementing Choosing Wisely in cancer care

Cancer and Suicide Risk in SGM Population

Lisocabtagene maraleucel is efficacious at treating R/R chronic lymphocytic leukaemia/small lymphocytic lymphoma

ASCO's efforts to improve global cancer care through the years

US NCI's global health initiatives at ASCO 2023

The Lancet Commission on Women and Cancer